{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:09:30Z","timestamp":1762283370807,"version":"build-2065373602"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Special project of Guangxi Natural Science Foundation","award":["2025GXNSFHA069143"],"award-info":[{"award-number":["2025GXNSFHA069143"]}]},{"name":"Middle-aged and Young Teachers\u2019 Basic Ability Promotion Project of Guangxi","award":["2025KY0559"],"award-info":[{"award-number":["2025KY0559"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22414-3","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:02:07Z","timestamp":1762282927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heterologous sequential immunization using chimeric mRNA and protein vaccines with HA-stem and S-RBD enhanced protective mucosal immunity against influenza and COVID-19"],"prefix":"10.1038","volume":"15","author":[{"given":"Yulei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"22414_CR1","unstructured":"Number of COVID-19 deaths reported to WHO (cumulative total). Updated 30 March 2025. Available from: https:\/\/data.who.int\/dashboards\/covid19\/deaths?n=c"},{"issue":"3","key":"22414_CR2","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.jinf.2023.06.011","volume":"87","author":"H Hagiya","year":"2023","unstructured":"Hagiya, H. et al. Global trends of seasonal influenza-associated mortality in 2001\u20132018: A longitudinal epidemiological study. J. Infect. 87(3), e54\u2013e7 (2023).","journal-title":"J. Infect."},{"issue":"12","key":"22414_CR3","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s41573-024-01041-z","volume":"23","author":"A Gupta","year":"2024","unstructured":"Gupta, A., Rudra, A., Reed, K., Langer, R. & Anderson, D. G. Advanced technologies for the development of infectious disease vaccines. Nat. Rev. Drug Discov.  23(12), 914\u2013938 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"22414_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.it.2025.02.012","volume":"46","author":"L Minute","year":"2025","unstructured":"Minute, L. et al. Trained immunity-based mucosal immunotherapies for the prevention of respiratory infections. Trends Immunol. 46(4), 270\u2013283 (2025).","journal-title":"Trends Immunol."},{"issue":"2","key":"22414_CR5","doi-asserted-by":"publisher","first-page":"e70056","DOI":"10.1002\/mco2.70056","volume":"6","author":"M Zhou","year":"2025","unstructured":"Zhou, M. et al. Novel vaccine strategies to induce respiratory mucosal immunity: Advances and implications. MedComm 6(2), e70056 (2025).","journal-title":"MedComm"},{"issue":"6","key":"22414_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","volume":"19","author":"F Krammer","year":"2019","unstructured":"Krammer, F. The human antibody response to influenza A virus infection and vaccination. Nat. Rev. Immunol. 19(6), 383\u2013397 (2019).","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"22414_CR7","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41591-021-01413-7","volume":"27","author":"T Kustin","year":"2021","unstructured":"Kustin, T. et al. Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals. Nat. Med. 27(8), 1379\u20131384 (2021).","journal-title":"Nat. Med."},{"key":"22414_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fimmu.2013.00128","volume":"4","author":"F Fiorino","year":"2013","unstructured":"Fiorino, F., Pettini, E., Pozzi, G., Medaglini, D. & Ciabattini, A. Prime-boost strategies in mucosal immunization affect local IgA production and The type of Th response. Front. Immunol. 4, 128 (2013).","journal-title":"Front. Immunol."},{"issue":"10","key":"22414_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","volume":"20","author":"M Jeyanathan","year":"2020","unstructured":"Jeyanathan, M. et al. Immunological considerations for COVID-19 vaccine strategies. Nat. Rev. Immunol. 20(10), 615\u2013632 (2020).","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"22414_CR10","doi-asserted-by":"publisher","first-page":"5800","DOI":"10.1038\/s41467-024-50087-5","volume":"15","author":"C Dong","year":"2024","unstructured":"Dong, C. et al. Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines. Nat. Commun. 15(1), 5800 (2024).","journal-title":"Nat. Commun."},{"issue":"6622","key":"22414_CR11","doi-asserted-by":"publisher","first-page":"eabo2523","DOI":"10.1126\/science.abo2523","volume":"378","author":"T Mao","year":"2022","unstructured":"Mao, T. et al. Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses. Science 378(6622), eabo2523 (2022).","journal-title":"Science"},{"issue":"1","key":"22414_CR12","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.1038\/s41467-021-27063-4","volume":"12","author":"D Lapuente","year":"2021","unstructured":"Lapuente, D. et al. Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization. Nat. Commun. 12 (1), 6871 (2021).","journal-title":"Nat. Commun."},{"issue":"3\u20134","key":"22414_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF01378634","volume":"131","author":"HX Lin","year":"1993","unstructured":"Lin, H. X., Gontier, C., Saron, M. F. & Perrin, P. A new immunostimulatory complex (PICKCa) in experimental rabies: Antiviral and adjuvant effects. Arch. Virol. 131(3\u20134), 307\u2013319 (1993).","journal-title":"Arch. Virol."},{"issue":"2","key":"22414_CR14","first-page":"113","volume":"4","author":"E Shen","year":"2007","unstructured":"Shen, E. et al. PIKA as an adjuvant enhances specific humoral and cellular immune responses following the vaccination of mice with HBsAg plus PIKA. Cell. Mol. Immunol. 4(2), 113\u2013120 (2007).","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"22414_CR15","doi-asserted-by":"publisher","first-page":"e1012508","DOI":"10.1371\/journal.ppat.1012508","volume":"20","author":"T Hao","year":"2024","unstructured":"Hao, T. et al. A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variants. PLoS Pathog. 20(9), e1012508 (2024).","journal-title":"PLoS Pathog."},{"issue":"2","key":"22414_CR16","doi-asserted-by":"publisher","first-page":"2231573","DOI":"10.1080\/22221751.2023.2231573","volume":"12","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD. Emerg. Microbes Infect.  12(2), 2231573 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"22414_CR17","doi-asserted-by":"crossref","unstructured":"Li Yulei, W. X., Xi, Z., Wenbo, R. & Pu, L. Protective efficacy of a universal influenza mRNAvaccine against the challenge of H1 and H5 influenza A virusesin mice. mLife 1\u20139 (2023).","DOI":"10.1002\/mlf2.12085"},{"issue":"10","key":"22414_CR18","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s41590-024-01951-5","volume":"25","author":"M Gagne","year":"2024","unstructured":"Gagne, M. et al. Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates. Nat. Immunol. 25(10), 1913\u20131927 (2024).","journal-title":"Nat. Immunol."},{"issue":"5","key":"22414_CR19","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1586\/erv.12.31","volume":"11","author":"MA Rose","year":"2012","unstructured":"Rose, M. A., Zielen, S. & Baumann, U. Mucosal immunity and nasal influenza vaccination. Expert Rev. Vaccines. 11(5), 595\u2013607 (2012).","journal-title":"Expert Rev. Vaccines"},{"issue":"104","key":"22414_CR20","doi-asserted-by":"publisher","first-page":"eado5937","DOI":"10.1126\/sciimmunol.ado5937","volume":"10","author":"E Ben-Akiva","year":"2025","unstructured":"Ben-Akiva, E., Chapman, A., Mao, T. & Irvine, D. J. Linking vaccine adjuvant mechanisms of action to function. Sci. Immunol. 10(104), eado5937 (2025).","journal-title":"Sci. Immunol."},{"issue":"1","key":"22414_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","volume":"8","author":"T Zhao","year":"2023","unstructured":"Zhao, T. et al. Vaccine adjuvants: Mechanisms and platforms. Signal. Transduct. Target. Ther. 8(1), 283 (2023).","journal-title":"Signal. Transduct. Target. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22414-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22414-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22414-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:02:09Z","timestamp":1762282929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22414-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22414"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22414-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38639"}}